Cite
HARVARD Citation
Brown, T. et al. (n.d.). Final analysis of a phase I/IIa trial of the folate‐binding protein‐derived E39 peptide vaccine to prevent recurrence in ovarian and endometrial cancer patients. Cancer medicine. pp. 4678-4687. [Online].